This document discusses regulations and standards that impact central service departments. It provides information on the differences between regulations and voluntary/regulatory standards. It reviews regulations from the FDA regarding medical device classification and labeling. It also discusses the roles of the CDC, DOT, EPA, and OSHA and how their regulations impact central service. Professional organizations that develop standards affecting central service are also reviewed.
CENTRAL STERILE PROCESSING TECHNICIAN. Certified Registered Central Service Technician (CRCST) exam. Example of slide presentation for corporate client
Cleaning, Disinfection, and Sterilization Validations of Reusable Medical Dev...Pacific BioLabs
This presentation provides important details on how to save time and money in the process of reusable medical device design. The main focus is on how device material choice and design affects the cleaning and disinfection process, and what considerations design engineers need to make when creating reusable medical devices.
The engineer's secrets for prevention of hospital acquired infectionsLallu Joseph
Engineering controls to be put in place in hospitals to prevent hospital acquired infections- HAI
Areas covered- Hand Hygiene Infrastructure, Reprocessing, Environmental Controls, Isolation Rooms, Operating Rooms, CSSD, Emergency Rooms, ICRA,
CENTRAL STERILE PROCESSING TECHNICIAN. Certified Registered Central Service Technician (CRCST) exam. Example of slide presentation for corporate client
Cleaning, Disinfection, and Sterilization Validations of Reusable Medical Dev...Pacific BioLabs
This presentation provides important details on how to save time and money in the process of reusable medical device design. The main focus is on how device material choice and design affects the cleaning and disinfection process, and what considerations design engineers need to make when creating reusable medical devices.
The engineer's secrets for prevention of hospital acquired infectionsLallu Joseph
Engineering controls to be put in place in hospitals to prevent hospital acquired infections- HAI
Areas covered- Hand Hygiene Infrastructure, Reprocessing, Environmental Controls, Isolation Rooms, Operating Rooms, CSSD, Emergency Rooms, ICRA,
COVID-19 and the FDA: What Every Manufacturing Company Needs to KnowEMMAIntl
Are you a manufacturer and want to help with the COVID-19 Pandemic? We invite you to attend our upcoming webinar to learn more about FDA’s temporary policies for regulating Personal Protective Equipment (PPE), Reprocessing, Ventilators and Hand Sanitizer manufacturing, and what you need to do to get your product on the market.
A presentation on Pharmacovigilance System in United States.
We at PharmXL International Pvt. Ltd., offer wide range of services for pharma industry like Pharmacovigilance services, Clinical Trials services, Regulatory Affairs services, Medical writing services etc to comply with required regulatory obligations across major regions.
For details visit: www.PharmXL.com
Email us: contact@pharmxl.com
Organization and objectives of ICH, expedited reporting, ICSR, PSURs, post approval expedited reporting, pharmacovigilance Planning, good clinical practices
Master formula record, DMF (Drug Master File), Distribution records. Generic drugs product development Introduction , Hatch-Waxman act and Amendments, CFR (CODE OF FEDERAL REGULATION) ,Drug product performance, In-vitro, ANDA regulatory approval process, NDA approval process, BE and drug product assessment, in –vivo, Scale up process approval changes, Post marketing surveillance, Outsourcing BA and BE to CRO
TGA Presentation: TGA focus and wrap up - What we've done, and what we still ...TGA Australia
An overview of the TGA's implementation of the recommendations made in the Review of Medicines and Medical Devices Regulation and other reforms for the IVD framework
A BRIEF OVERVIEW ABOUT CDSCO.
YOU CAN DOWNLOAD FILES FROM HERE-
MY SLIDESHARE ACCOUNT-
https://www.slideshare.net/varshawadnere
IF YOU HAVE ANY DOUBTS YOU CAN ASK ME THROUGH EMAIL-
pharmacypharmd8@gmail.com
THANK YOU.
MRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptxDimple Marathe
organization, structure, function of FDA, FR, CFR, FFDCA, Approval process of IND, NDA, ANDA, orphan drug, combination product, changes to approved NDA, ANDA, packaging labelling of pharmaceutical.
Presentation: Regulation of personalised, including 3D printed, medical devicesTGA Australia
The status of making custom made devices exempt from registration is being looked at by TGA. But with the proliferation of 3D printing, we are getting more personalised medical devices. What is the right balance to enable innovation but having the right control to avoid major issues. This session is aimed at a more senior audience.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
2. ∗ Tell the difference between regulations and voluntary and
regulatory standards
∗ Provide basic information about the U.S. Food and Drug
Administration (FDA), and review its regulations applicable to:
∗ Medical device classification
∗ Pre- and post-market requirements
∗ Medical device reporting requirements
∗ Medical device recalls
∗ FDA labeling document
∗ Re-use of single-use medical devices
∗ Explain the roles and responsibilities of other federal
governmental agencies that impact Central Service, and discuss
important aspects of the regulations and standards they administer:
∗ Centers for Disease Control (CDC)
∗ Department of Transportation (DOT)
∗ Environmental Protection Agency (EPA)
∗ Occupational Safety and Health Administration (OSHA)
Learning Objectives:
3. ∗ Discuss the assistance provided by professional
associations that develop regulations and standards
affecting Central Service:
∗ Association for the Advancement of Medical Instrumentation
(AAMI)
∗ American National Standards Institute (ANSI)
∗ Association of Operating Room Nurses (AORN)
∗ Association for Professionals in Infection Central and Epidemiology
(APIC)
∗ International Standards Organization (ISO)
∗ The Joint Commission
∗ National Fire Protection Association (NFPA)
∗ United States Pharmacopoeia – National Formulary (USP-UF)
∗ World Health Organization (WHO)
∗ Society of Gastroenterology Nurses and Associates (SGNA)
Learning Objectives - continued
4.
5. ∗A Mandatory Law or Rule
that is issued by a
governing body.
Regulation:
6. ∗A uniform method of
defining basic parameters
for processes, products,
services, and measurements.
Standard:
7. ∗ Regulatory: A comparison benchmark that is
mandated by a governing agency and if not
complied with, may cause a facility to be in
violation and liable for a legal penalty.
∗ Voluntary: A comparison benchmark that is
strongly recommended by a governing agency
or professional organization that provides
recommendations and guidelines to provide
better patient care.
Types of Standards
8. ∗ A written and enforceable law enacted by a
governing body.
∗ Voluntary Standards are sometimes incorporated
into Federal, State, or Local Statutes.
Statute
9. ∗ Compliance with regulations is mandatory and failure to comply can
lead to serious legal consequences for the healthcare facility.
∗ Many regulations are voluntary guidelines focus on workplace
safety.
∗ Awareness of regulations and standards can help with decisions
regarding the acquisition and use of products in Central Service.
∗ Knowledge of regulatory requirements and state of the art
professional practices enhances the professional growth of each
Central Service Technician.
∗ Careful compliance with Standards and Regulations protects the
welfare of patients.
Central Service Technicians Must be Familiar with
Regulations and Standards because:
10. Federal Regulatory Agencies
∗ Food and Drug Administration (FDA)
∗ Centers for Disease Control (CDC)
∗ Department of Transportation (DOT)
∗ Environmental Protection Agency (EPA)
∗ Occupational Safety and Health
Administration (OSHA)
11. ∗ Functions with the Public Health Service in the US
Department of Health and Human Services.
∗ Regulates:
∗Sterilants
∗High Level Disinfectants
∗The manufacturer of all Medical Devices
Requires pre-market clearance of new Medical Devices.
FDA
12. Classification of Medical Devices
∗Class I Devices - Subject to general
controls, exempt from pre-market
submission requirements.
∗Low Risk Products such as:
∗ Ultrasonic Cleaners
∗ Most Hand-Held Surgical Instruments
13. Class II Devices
∗ Class II Devices – Considered to pose
potential risks. Subject to special
requirements and post market surveillance.
Manufacturers required to submit pre-
market notification (510K).
∗ Pose a potential risk. Subject to
Performance Standards. Include:
∗ Sterilizers
∗ Biological Indicators
∗ Chemical Indicators
∗ Packaging
14. Class III Devices
∗ Class III Devices – Most Stringently
regulated devices. Require pre-market
application and extensive testing
demonstrating their safety and
effectiveness before approval.
∗ Most stringently regulated. Include:
∗ Heart Valves
∗ Infant Radiant Warmers
∗ Pacemakers
∗ Other Implants
15. ∗ Safe Medical Devices Act of 1990
∗ Healthcare Facilities required to report events
to the FDA.
∗ Beginning in 2000, medical facilities were
required to report suspected medical device-
related deaths with 10 working days. Serious
injuries must also be reported.
Medical Device Reporting
16. Medwatch Program
∗ Provides for voluntary
reporting of device-related
problems.
∗ Provides a vehicle for
Healthcare Professionals to
notify the FDA of problems.
17. ∗ An action taken if there is a with a medical device
that violates FDA regulations.
∗ Can be enforced when a device is defective and/or
poses a risk to health.
∗ Can be voluntary when instituted by the
manufacturer, distributor, or other interested party.
Medical Device Recalls
18. ∗ Class I – High Risk: There is a chance the product will cause
serious health problems or death.
∗ Class II – Less Serious Risk: There is a chance the product will
cause temporary or reversible health problems. There is a
remote chance the device will cause serious health problems.
∗ Class III – Low Risk: There is little chance that using or being
exposed to the product will cause health problems.
Categories of FDA Recalls:
19. ∗ “Re-labeling Reusable Medical Devices for
Reprocessing in Healthcare Facilities”, 1996
∗ The document requires manufacturers to comply with
seven criteria, mostly involving reprocessing
instructions, when they submit medical device
applications to the FDA for evaluation.
FDA Labeling Document
20. ∗ Provide sufficient instructions on how to prepare the device
for the next patient.
∗ Provide documentation of test that show that the instructions
are adequate and can be reasonably executed by users.
FDA Labeling Document
Manufacturers are Responsible to:
21. ∗ Confirm that they have the facilities and equipment to execute
the instructions.
∗ Ensure that the instructions are followed.
FDA Labeling Document
Users are Responsible to:
22. Reuse of Single Use Medical Devices
∗ Single Use
Devices (SUDs)
∗ Labeled as:
∗ Single Use
∗ One Time Use
Any Institution that Reuses an SUD
Should be able to demonstrate that:
∗ The item can be adequately cleaned
and sterilized
∗ The quality of the device will not be
adversely affected
∗ The device will remain safe and
effective for its intended use
23. ∗ All Hospitals and Third Party Reprocessors who
reprocess SUDs are required to be in compliance
with pre-market and post-market requirements
outlined in “Enforcement Priorities for Single-Use
Devices Reprocessed by Third Parties and
Hospitals”, FDA 2000.
FDA Enforcement Requirements for
Reprocessing SUDs.
24. ∗ Re-use options should be considered by a multidisciplinary
task force that can evaluate the legal, ethical, and economic
issues involved
∗ If the hospital chooses to reprocess, they are subject to
stringent FDA regulations and on-site surveys
∗ Hospitals may choose to outsource that process to Third
Party Reprocessors
Hospital Re-use Options
25. ∗ Have received FDA Clearance to reprocess SUDs.
∗ Must show evidence of quality and testing.
Third Party Reprocessors
26. ∗ Preliminary Evaluation
∗ Evaluation of Reuse Alternative
∗ Initial Cost Analysis
∗ Risk Assessment
∗ Consideration of Reprocessing Protocols
∗ Examine Facility Requirements
∗ Develop Procedures
∗ Undertake Potential Cost Assessment
∗ Obtain Necessary Approval
∗ Conduct Clinical Study
∗ Undertake Actual Cost Assessment
∗ Implement SUD Reprocessing System
SUD Considerations
27. Other Federal Regulatory Agencies
∗ Centers for Disease Control (CDC)
∗ Department of Transportation
(DOT)
∗ Environmental Protection Agency
(EPA)
∗ Occupational Safety and Health
Administration (OSHA)
28. ∗ Federal agency the collects and analyses data about
infectious diseases.
∗ Issues infection control guidelines.
∗ Many CDC Guidelines and Recommendations are
incorporated into healthcare facility policies and
procedures and other agencies rely heavily on them.
CDC
CENTERS FOR DISEASE CONTROL
29. ∗ Federal Government agency that is dedicated to ensuring
a fast, safe, and efficient transportation system
∗ DOT regulates labeling and containment of Hazardous
Waste, Biohazard items and minimally processed items
for transport
∗ Dot also regulates labeling and containment of
radioactive materials for transport
DOT
DEPARTMENT OF TRANSPORTATION
30. ∗ Central Service Department that transport minimally
cleaned items between facilities for processing are
impacted by DOT regulations.
∗ Minimally cleaned instruments that are transported
to repair facilities must be shipped following DOT
regulations.
DOT
31. State or Local DOT
∗ State or Local DOT
regulations may be more
restrictive than Federal
DOT regulations
∗ When that happens, the
most stringent regulations
apply
32. ∗ Established in 1970 to
enforce Federal laws
pertaining to Air and
Water Pollution and
other environmentally-
related statutes.
EPA
ENVIRONMENTAL PROTECTIVE AGENCY
33. ∗ Minimizing Greenhouse Gasses
∗ Minimizing Toxic Emissions
∗ Regulating the Re-use of Solid Wastes
∗ Controlling indoor air pollution
∗ Developing and enforcing pesticide regulations
The EPA is Responsible for:
34. ∗ Federal Insecticide,
Fungicide and
Rodenticide Act (FIFRA)
gave the EPA
responsibility to regulate
all products with
antimicrobial claims,
such as Sterilants,
Disinfectants, and
Sanitizers.
EPA
∗ All surface disinfectants
and sanitizers must be
registered with the EPA.
∗ All products must meet
strict labeling
requirements.
35. ∗ Manufacturers must obtain an EPA registration
number for every chemical sterilant, disinfectant
and sanitizer.
∗ Each product’s label must contain:
∗ Product Ingredients
∗ Directions for Use
∗ Product Precautions and Warnings
∗ Directions for Storage and Disposal
∗ The EPA Registration Number
EPA – FIFRA Requirements
36. ∗ National Emissions Standards for Hazardous Air
Pollutants (NESHAP) set emissions standards for
industrial Ethylene Oxide Sterilization Facilities.
∗ Regulate Medical Waste Incinerators
Clean Air Act Amendments
37. ∗Created in 1971 as a part of the U.S.
Department of Labor
∗Its primary role is to protect workers
from occupationally-caused illnesses
and injuries.
OSHA
Occupational Safety and Health Administration
38. ∗ “That each employer furnish to each of his employees
employment and a place of employment which are
free from recognized hazards that are causing, or are
likely to cause, death or serious physical harm to his
employees.”
∗A Safe Workplace
OSHA Requires:
39. OSHA’s Impact on Central Service
∗ Employee exposure to
hazardous and/or toxic
chemicals.
∗ Employee exposure to
Bloodborne Pathogens.
∗ Protect employees from
other potential hazards.
41. ∗ Willful: A violation that the employer intentionally
and knowingly commits. These carry fines and
penalties of $5000 to $70,000.
∗ Serious: A violation in which there is substantial
probability that death or serious injury could result
and the employer knew or should have known of the
hazard. These violations carry fines up to $7000.
OSHA Violation Ratings:
42. ∗ Repeat: A violation of any standard
regulation or rule where, upon reinspection,
a substantially similar violation is found.
These carry penalties of up to $70,000.
∗ Failure to Abate: Failure to correct a prior
violation may result in penalties of up to
$7000 per day.
OSHA Violation Ratings continued:
43. ∗ Federal Regulations apply to ALL States.
∗ States may have State OSHA Offices as well.
Those agencies may be more stringent (but
never less stringent) than the Federal
regulations.
OSHA
44. ∗ State agencies such as DHS, DOT, EPA and OSHA
may have regulations that are more stringent
than Federal regulations
∗ The most restrictive regulations always apply
State Agencies
46. ∗ Voluntary Concensus Organization with a membership of over
6000 individuals and 375 organizations
∗ Uses Technical Advisory Groups comprised of practitioners,
industry experts and manufacturers to develop Recommended
Practices and Standards
∗ Even though it is a voluntary organization, its Recommended
Practices and Standards are used by regulatory organizations
that inspect healthcare organizations
AAMI:
Association for the Advancement of
Medical Instrumentation
47. ∗ Mission: “Enhance the global competitiveness of U.S.
business and the American Quality of life by
promoting and facilitating voluntary consensus
standards and ensuring their integrity.”
∗ Standards are submitted to ANSI for approval, from
other organizations such as AAMI (Association for
the Advancement of Medical Instrumentation)
ANSI:
American National Standard Institute
48. ∗ Professional Organization dedicated to providing
optimal care to the surgical patient
∗ Regulatory officials look for compliance with
AORN Standards, Recommended Practices and
Guidelines
AORN:
Association of Peri-Operative Nurses
49. ∗ Voluntary international organization dedicated to
the prevention and control of infections and
related outcomes
∗ Works with the CDC and other related agencies to
adopt standards for infection/disease prevention
APIC:
Associations for Professionals in Infection Control
& Epidemology
50. ∗ Globally based – non-governmental standards
organization
∗ Represents approximately 156 member countries
∗ Standards groups such as AAMI submit standards
which are granted ISO status based on the
consensus of the membership
ISO:
International Standards Organization
51. The Joint Commission
(formerly) The Joint Commission’s Mission
“To continuously improve the safety and quality of care
provided to the public through the provision of health
care accreditation and related services that support
performance improvement in hospitals.
52. ∗ Independent, Not-for-profit, Organization
∗ Sets Healthcare Quality Standards
∗ Is used as a measurement of organizational quality
∗ Surveys approximately 15,000 healthcare facilities in
the United States
∗ Conduct on-site surveys (inspections) of healthcare
facilities
∗ Surveys may be announced or unannounced
∗ Loss of Joint Commission Accreditation may result in
forfeiture of Medicare and Medicaid reimbursement
payments
The Joint Commission
53. ∗ International organization that works to reduce the
burden of fire and other hazards.
∗ Made up of representatives from nearly 100 nations and
organizations.
∗ Sets Fire Safety Standards.
NFPA:
National Protection Association
54. ∗ Creates and revises standards for medicines,
dosages, forms, drug substances, and dietary
supplements.
∗ Sets standards for packaging, labeling,
bacteriological purity, pH, and mineral content
of purified water or water sterilized for
irrigation.
USP-NF:
United States Pharmacopia-National Formulatory
55. ∗ An agency of the United Nations that was
established in 1948 to further international
cooperation in improving health conditions.
∗ Its major task is to combat infectious disease and
promote the general health of the peoples of the
world.
∗ Agencies such as the CDC may base their policies
on WHO guidelines and research.
WHO:
World Health Organization
56. ∗Sets healthcare standards for
Europe in much the same way
that AAMI sets standards in the
United States
ECHN:
European Commission for Standardization
57. ∗ A non-profit organization that collects information
and establishes standards and guidelines relating
to the processing of flexible endoscopes.
SGNA: Society of Gastroenterology Nurses
and Associates
58. ∗ Becoming familiar with the standards and regulations
that impact their jobs.
∗ Learning and correctly following procedures.
∗ Calling attention to poor practices.
∗ Keeping abreast of changes in standards and regulations.
∗ Putting ourselves in the Patient’s place. What quality
of care would you like to receive?
Central Service Technicians can insure
compliance by